Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Addressing pain and disease on the fly

07.12.2011
How fruit flies can teach us about curing chronic pain and halting mosquito-borne diseases

Studies of a protein that fruit flies use to sense heat and chemicals may someday provide solutions to human pain and the control of disease-spreading mosquitoes.

In the current issue of the journal Nature, biologist Paul Garrity of the National Center for Behavioral Genomics at Brandeis University and his team, spearheaded by KyeongJin Kang and Vince Panzano in the Garrity lab, report how fruit flies distinguish the warmth of a summer day from the pungency of wasabi by using TRPA1, a protein whose human relative is critical for contolling pain and inflammation.

In earlier research Garrity’s team showed that flies, like humans, sense chemical irritants with TRPA1, indicating an ancient origin for harmful chemical sensing. In 2008, the team demonstrated that this protein serves a second function in flies: sensing warmth.

Gentle warmth and nasty chemicals trigger distinct responses. How can both responses rely on the same sensor? The team has now discovered that there is an easy answer. Insects actually make two forms of TRPA1, one specialized for each task.

What is the significance of this new research?

Such TRPA1 specialization has implications for devising bug sprays and traps to combat the transmission of diseases like malaria, dengue and West Nile virus. “This work on TRPA1 can explain how blood-sucking insects like mosquitoes discriminate noxious chemicals, which repel them, from the warmth of a human, which attracts them,” says Garrity. “By activating one kind of TRPA1 you might be able to deter mosquitoes from biting you, while activating the other kind of TRPA1 might lure mosquitoes to a trap.”

These findings also have implications for understanding the way that human damage-sensing neurons work, explains Garrity. Since human TRPA1 is a drug target aimed at treating diseases such as asthma, migraines, and chronic pain, Garrity says it’s important to understand how TRPA1 proteins operate.

“Fruit flies are easy to work with in the lab and this lets us test hypotheses about how TRPA1 operates quickly and relatively cheaply.” Says Garrity. “Fortunately, the function of TRPA1 seems evolutionarily ancient and conserved from flies to mosquitoes to humans, so one can gain insights of general biomedical relevance using flies.”

“Untreatable chronic pain and insect-borne diseases are two major human health problems,” says Garrity. “When you think about basic research translating into treatments to help people, work in these areas has tremendous potential for easing human misery.”

The study was funded by the National Science Foundation, National Institute of Mental Health and the National Institute of Neurological Disorders and Stroke.

Susan Chaityn Lebovits | EurekAlert!
Further information:
http://www.brandeis.edu

More articles from Life Sciences:

nachricht Biophysicists reveal how optogenetic tool works
29.05.2020 | Moscow Institute of Physics and Technology

nachricht Mapping immune cells in brain tumors
29.05.2020 | University of Zurich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>